SCHEMBL7494560

SCHEMBL7494560

COCn1c2ccc(F)cc2c2c(CBr)nn(-c3ccccc3)c(=O)c21

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ TSPO P30536 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ PIK3R1 P27986 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ PER2 O15055 2/20 0.34
▸ CRY2 Q49AN0 1/20 0.34
▸ GUCY1A1 Q02108 1/20 0.33
▸ GUCY1B1 Q02153 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7497413 0.91 MAPT (0.42) LMNAATMTSPOJAK2JAK3
SCHEMBL7497415 0.89 KDM4E (0.41) TSPOJAK2JAK3MAPK14MAPT
SCHEMBL7497760 0.87 KDM4E (0.38) LMNAATMTSPOJAK2JAK3
SCHEMBL7490382 0.84 MEN1 (0.42) MAPTKDM4EALDH1A1PTGDR2
SCHEMBL7497068 0.81 DHODH (0.46) TSPOJAK2JAK3MAPK14MAPT
SCHEMBL7751642 0.80 MAPT (0.49) MAPTKDM4EALDH1A1
SCHEMBL7750629 0.77 TSPO (0.45) TSPOMAPTKDM4EALDH1A1PTGDR2
SCHEMBL7499843 0.76 CYP1A2 (0.41) TSPOJAK2JAK3MAPK14PIK3R1
SCHEMBL7494156 0.74 TSPO (0.58) TSPO
SCHEMBL7750405 0.73 SMN1; SMN2 (0.45) MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000063-B1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY SANOFI SYNTHELABO (FR) 2002-10-23 — — EP disclosed
US-6262045-B1 TREATMENT OF ANXIETY; SLEEP DISORDER; EPILEPSY; SPASTICITY; MUSCLE CONTRACTURE OR AN EXTRAPYRAMIDAL SYNDROM; INDUCING OR MAINTAINING ANAESTHESIA SANOFI-SYNTHELABO (FR) 2001-07-17 — — US disclosed
Send feedback